Loading...

171 posters, 10 topics, 5 sessions, 690 authors, 211 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

American Association of Plastic Surgeons Meeting 2022

April 9 - 12 | San Diego, California

American Association of Plastic Surgeons Meeting 2022 banner

P153

Outcomes Of Abdominal Wall Reconstruction Using Acellular Dermal Matrix In High-risk CDC Class III And IV Defects

Part of Topic

Outcomes

Outcomes Of Abdominal Wall Reconstruction Using Acellular Dermal Matrix In High-risk CDC Class III And IV Defects
Abbas M Hassan, MD; Malke Asaad, MD; Anaeze C Offodile II, MD, MPH, FACS; Charles E Butler, MD, FACSDepartment of Plastic and Reconstructive Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.
Background
>400,000 operations
performed annually in the US alone.
Costs >$3 billion
AWR in the presence of bacterial contamination is challenging
Conclusion
Patients with class IV defects have a higher risk of SSOs, but not HR or SSIs
Safe and durable long-term outcomes are achievable in single-stage AWR using xenogeneic mesh for CDC class III/IV defects despite the high level of defect contamination
Contamination Level
Acellular Dermal Matrix (ADM)
Rapid revascularization
Fibroblast stimulation
Cellular
infiltration
Soft tissue
incorporation
Knowledge gap
Optimal mesh selection in class III/IV defects is controversial
Outcomes using ADM are lacking
Objective
Evaluate the long-term outcomes of AWR using Porcine ADM and bovine ADM in patients with CDC class III and IV defects
Methods
Retrospective cohort study
March 2005 to June 2019
The University of Texas MD Anderson Cancer Center
AWR of Class III and IV patients
Primary outcome: Hernia recurrence (HR)
Secondary outcomes: Surgical site occurrences (SSOs) and surgical site infections (SSIs)
Results
725 Patients
CDC Wound Classification
101
Class III/IV
322
Class II
302
Class I
Patients with class III/IV had HR rate of 21%, SSO rate of 49%, and SSI rate of 24
Class IV defects were predictive of SSOs (odds ratio [OR], 2.88; 95% confidence interval [CI], 1.11–7.42; P = 0.029) but not HR (HR, 1.60; 95% CI, 0.59–4.34; P = 0.355) or SSIs (OR, 2.62; 95% CI, 0.85–8.10; P = 0.094).
Figure 1. Kaplan–Meier curve for hernia recurrence
Limitations
Single-institution retrospective design confounding/bias
Lack of synthetic mesh control
No patient-reported outcomes
Evaluated only the two most common ADMs
References
Contacts for authors
American Association of Plastic Surgeons Meeting 2022 » banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.